Cambium Biomaterials, Inc.
Advanced material solutions—from AI-driven design to agile U.S. manufacturing—for defense, aerospace, & high-performance applications
Funding history
About Cambium Biomaterials, Inc.
How much funding has Cambium Biomaterials, Inc. raised?
Cambium Biomaterials, Inc. has raised $94.4M in total funding. The most recent round was Series B.
Where is Cambium Biomaterials, Inc. headquartered?
Cambium Biomaterials, Inc. is headquartered in El Segundo, CA.
What does Cambium Biomaterials, Inc. do?
Advanced material solutions—from AI-driven design to agile U.S. manufacturing—for defense, aerospace, & high-performance applications
What problem does Cambium Biomaterials, Inc. solve?
Products that must perform in extreme conditions across land, air, sea, and space face critical challenges that require new advanced material solutions.
What's Cambium Biomaterials, Inc.'s solution?
Cambium develops high-performance materials, including thermal protection systems, high-temperature structural materials, and laser/directed energy protection, that are stronger, lighter, and more resilient.
What makes Cambium Biomaterials, Inc. different?
It uses AI-driven molecular design and agile domestic manufacturing to test and deliver materials 10x faster than conventional development, and recently acquired SHD Group to expand its global manufacturing footprint.
What makes Cambium Biomaterials, Inc. notable?
Cambium Biomaterials, co-founded and led by CEO Simon Waddington, closed a $19M Series A led by 8VC to develop advanced biomaterials for defense applications.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.